BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 5 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 5 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 5 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 6 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 6 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 7 hours ago Atmus Welcomes Heath Sharp to Board of Directors 9 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 9 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 5 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 5 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 5 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 6 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 6 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 7 hours ago Atmus Welcomes Heath Sharp to Board of Directors 9 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 9 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Market News

Despite uncertainties, cannabis firms emerge as top takeover targets

In all probability, 2019 will be the year of cannabis as far as Wall Street is concerned. After the beverages and healthcare companies, the tobacco industry is now looking to tap the potential of marijuana. According to reliable sources, tobacco giant Altria Group (MO) is in early-stage discussions with the management of Canada-based cannabis company […]

December 3, 2018 2 min read

In all probability, 2019 will be the year of cannabis as far as Wall Street is concerned. After the beverages and healthcare companies, the tobacco industry is now looking to tap the potential of marijuana. According to reliable sources, tobacco giant Altria Group (MO) is in early-stage discussions with the management of Canada-based cannabis company Cronos Group (CRON) to acquire the latter.

In the changed scenario, tobacco firms keep looking for suitable avenues to diversify their business, concerned over the uncertainties surrounding the production and sale of the traditional cigarette. Cigarette companies can use marijuana for value addition more effectively than any other industry.

Altria is reportedly in talks with Canada-based cannabis company Cronos Group to acquire the latter

Altria, which is known for its popular cigarette brands like Marlboro, reportedly held talks with e-cigarette company Juul recently to acquire a major stake in it. Meanwhile, no deal has been confirmed between Altria and its potential buyout targets yet.

The tobacco industry is currently going through a difficult phase, amid falling cigarette sales mainly due to the low demand among youngsters. Though the emergence of e-cigarette as a ‘healthier’ alternative to traditional tobacco products is seen as a positive sign, vaping devices are currently facing regulatory restrictions for the potential risks they pose.

FDA adds restrictions on sale of e-cigarettes

ADVERTISEMENT

Cannabis, which is being legalized in more and more markets, is steadily gaining acceptance as a raw material in the production of certain medical formulation and soft drinks. If the Altria-Cronos deal materializes, it would mark the beginning of a new trend, for it would be the first time a tobacco company venturing into pot-based business in a full-fledged manner.

Soon after the media reports, Cronos (CRON) shares gained about 12% Monday. A similar spike was witnessed in the price of Altria’s stock, which moved up around 2%, recovering from the recent plunge that dragged it to a four-year low.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

ADVERTISEMENT